We are live on ! Find out more
ARIA

Ariad Pharmaceuticals Inc
ARIA

Delisted

ARIA was delisted on the 15th of February, 2017.

Back to rankings

179 hedge funds and large institutions have $888M invested in Ariad Pharmaceuticals Inc in 2014 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 49 increasing their positions, 50 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 22

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

36% more capital invested

Capital invested by funds: $655M → $888M (+$233M)

6% more funds holding

Funds holding: 169 → 179 (+10)

2% less repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 50

8% less call options, than puts

Call options by funds: $32M | Put options by funds: $34.7M

Holders
179
Holders Change
+10
Holders Change %
+5.92%
% of All Funds
4.77%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.16%
New
34
Increased
49
Reduced
50
Closed
22
Calls
$32M
Puts
$34.7M
Net Calls
-$2.74M
Net Calls Change
+$3.27M

Top Buyers

Rank Fund Capital Flow
1
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$52M
2
PI
Putnam Investments
Massachusetts
+$18.8M
3
PC
PointState Capital
New York
+$10.3M
4
CCM
Camber Capital Management
Massachusetts
+$9.38M
5
AIMCA
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
+$8.63M

Top Sellers

Rank Fund Capital Flow
1
HM
HealthCor Management
New York
-$12.8M
2
Millennium Management
Millennium Management
New York
-$8.89M
3
DFO
Duquesne Family Office
New York
-$8.88M
4
JP Morgan Chase
JP Morgan Chase
New York
-$6.85M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$6.25M
Name Holding Trade Value Shares
Change 		Change in
Stake
California State Teachers Retirement System (CalSTRS)
51
California State Teachers Retirement System (CalSTRS)
California
$2.1M +$8.14K +1,301 +0.4%
GTC
52
Ghost Tree Capital
New York
$2.06M -$2.5M -400,000 -57%
ABI
53
Adamant Biomedical Investments
Switzerland
$2.06M – – –
EEG
54
E.E. Geduld
$2.01M +$125K +20,000 +7%
MIG
55
Mariner Investment Group
New York
$1.99M -$313K -50,000 -15%
Renaissance Technologies
56
Renaissance Technologies
New York
$1.93M -$6.07M -971,300 -78%
Wells Fargo
57
Wells Fargo
California
$1.91M +$224K +35,801 +15%
UBS Group
58
UBS Group
Switzerland
$1.7M +$1.54M +246,608 New
TA
59
Teachers Advisors
New York
$1.57M – – –
Swiss National Bank
60
Swiss National Bank
Switzerland
$1.35M – – –
State Board of Administration of Florida Retirement System
61
State Board of Administration of Florida Retirement System
Florida
$1.26M – – –
NCMW
62
Northern Capital Management (Wisconsin)
Wisconsin
$1.19M -$65.7K -10,500 -6%
ProShare Advisors
63
ProShare Advisors
Maryland
$1.09M -$15.4K -2,459 -2%
Deutsche Bank
64
Deutsche Bank
Germany
$1.03M +$45.7K +7,299 +5%
HVC
65
Healthcare Value Capital
New Jersey
$1.03M +$313K +50,000 +50%
TI
66
Trexquant Investment
Connecticut
$1.02M +$933K +149,200 New
American Century Companies
67
American Century Companies
Missouri
$1.02M +$45.4K +7,265 +5%
SC
68
Skylands Capital
Wisconsin
$990K – – –
Millennium Management
69
Millennium Management
New York
$980K -$8.89M -1,420,635 -91%
RhumbLine Advisers
70
RhumbLine Advisers
Massachusetts
$942K -$32.6K -5,218 -4%
MLICM
71
Metropolitan Life Insurance Company (MetLife)
New York
$881K – – –
NFA
72
Nationwide Fund Advisors
Ohio
$861K -$12.9K -2,056 -2%
BG
73
BlackRock Group
United Kingdom
$831K +$148K +23,652 +24%
Barclays
74
Barclays
United Kingdom
$783K +$289K +46,261 +55%
PIM
75
Platinum Investment Management
Australia
$771K – – –
1 2
3
4 5

ARIA Hedge Fund Activity: Q4 2014 in Review

179 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q4 2014, worth a combined $888M — up 36% from $655M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new ARIA positions and 22 closed out — a net gain of 12 holders — while 49 added to existing stakes and 50 trimmed.

The largest buyer was Westfield Capital Management, opening a new position worth an estimated $52M. The largest seller was HealthCor Management, exiting entirely with an estimated $12.8M sold.

  • 179 institutional investors held Ariad Pharmaceuticals Inc (ARIA) as of Q4 2014, up from 169 in Q3 2014.
  • Funds reported $888M of Ariad Pharmaceuticals Inc stock for Q4 2014, up 36% quarter-over-quarter.
  • 34 funds opened new Ariad Pharmaceuticals Inc positions in Q4 2014 and 22 closed out, a net change of +12 holders.
  • The largest Ariad Pharmaceuticals Inc buyer in Q4 2014 was Westfield Capital Management, an estimated $52M added.
  • The largest Ariad Pharmaceuticals Inc seller in Q4 2014 was HealthCor Management, an estimated $12.8M sold.

Based on aggregated 13F filings for Q4 2014.